Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crystal Watson

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
JMIR Public Health and Surveillance|April 27, 2026
Integrating AI Into Governmental Public Health Decision Making: Challenges, Considerations, and a Path ForwardElizabeth Campbell, Oluremilekun Oyefolu, Sarah Gillani, et al.
Disaster Medicine and Public Health Preparedness|March 25, 2021
Risk and the Republican National Convention: Application of the Novel COVID-19 Operational Risk AssessmentDavid Callaway, Jeff Runge, Lucia Mullen, et al.
Clinical Therapeutics|January 31, 2012
Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database studyMachaon M K Bonafede, Kathleen M Fox, Barbara H Johnson, et al.
Advances in Therapy|March 8, 2014
Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sampleJason Yeaw, Crystal Watson, Kathleen M Fox, et al.
Journal of Managed Care Pharmacy : JMCP|October 1, 2013
Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care populationVernon F Schabert, Crystal Watson, George J Joseph, et al.
Frontiers in Public Health|April 24, 2026
Effectiveness of public health measures and strategies to reduce risk of spread of respiratory pathogens at sporting mass gatherings: systematic literature reviewLucia Mullen, Amanda Kobokovich Mui, Crystal Watson, et al.
Health Security|April 19, 2017
The Joint External Evaluation of Taiwan: The External Evaluators' PerspectiveEric S Toner, Jennifer B Nuzzo, Matthew Shearer, et al.
Politics and the Life Sciences : the Journal of the Association for Politics and the Life Sciences|March 4, 2025
Diplomacy disrupted: A mixed-methods analysis of Russian disinformation at the Ninth Review Conference of the Biological and Toxin Weapons ConventionAnnie E Sundelson, Gigi Kwik Gronvall, Gary Ackerman, et al.
Frontiers in Public Health|March 19, 2026
Impact, use, and implications of artificial intelligence in public health decision making by elected officials: a scoping reviewElizabeth A Campbell, Hannah Goodtree, Sarah Gillani, et al.
Arthritis Care & Research|April 5, 2013
Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United StatesDevon Hone, Annie Cheng, Crystal Watson, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
JMIR Public Health and Surveillance|April 27, 2026
Integrating AI Into Governmental Public Health Decision Making: Challenges, Considerations, and a Path ForwardElizabeth Campbell, Oluremilekun Oyefolu, Sarah Gillani, et al.
Disaster Medicine and Public Health Preparedness|March 25, 2021
Risk and the Republican National Convention: Application of the Novel COVID-19 Operational Risk AssessmentDavid Callaway, Jeff Runge, Lucia Mullen, et al.
Clinical Therapeutics|January 31, 2012
Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database studyMachaon M K Bonafede, Kathleen M Fox, Barbara H Johnson, et al.
Advances in Therapy|March 8, 2014
Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sampleJason Yeaw, Crystal Watson, Kathleen M Fox, et al.
Journal of Managed Care Pharmacy : JMCP|October 1, 2013
Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care populationVernon F Schabert, Crystal Watson, George J Joseph, et al.
Frontiers in Public Health|April 24, 2026
Effectiveness of public health measures and strategies to reduce risk of spread of respiratory pathogens at sporting mass gatherings: systematic literature reviewLucia Mullen, Amanda Kobokovich Mui, Crystal Watson, et al.
Health Security|April 19, 2017
The Joint External Evaluation of Taiwan: The External Evaluators' PerspectiveEric S Toner, Jennifer B Nuzzo, Matthew Shearer, et al.
Politics and the Life Sciences : the Journal of the Association for Politics and the Life Sciences|March 4, 2025
Diplomacy disrupted: A mixed-methods analysis of Russian disinformation at the Ninth Review Conference of the Biological and Toxin Weapons ConventionAnnie E Sundelson, Gigi Kwik Gronvall, Gary Ackerman, et al.
Frontiers in Public Health|March 19, 2026
Impact, use, and implications of artificial intelligence in public health decision making by elected officials: a scoping reviewElizabeth A Campbell, Hannah Goodtree, Sarah Gillani, et al.
Arthritis Care & Research|April 5, 2013
Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United StatesDevon Hone, Annie Cheng, Crystal Watson, et al.
Pageof 7